NASDAQ:MOTS - Motus GI Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.39 +0.03 (+0.69 %)
(As of 01/17/2019 04:00 PM ET)
Previous Close$4.36
Today's Range$4.31 - $4.4474
52-Week Range$2.34 - $10.66
Volume57,930 shs
Average Volume69,433 shs
Market Capitalization$66.06 million
P/E Ratio-3.43
Dividend YieldN/A
BetaN/A
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MOTS
CUSIPN/A
Phone786-459-1831

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10,000.00

Profitability

Net Income$-13,200,000.00

Miscellaneous

Employees39
Market Cap$66.06 million
OptionableNot Optionable

Motus GI (NASDAQ:MOTS) Frequently Asked Questions

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

How were Motus GI's earnings last quarter?

Motus GI Holdings Inc (NASDAQ:MOTS) released its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.33) EPS for the quarter, missing the Zacks' consensus estimate of ($0.27) by $0.06. View Motus GI's Earnings History.

When is Motus GI's next earnings date?

Motus GI is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Motus GI.

What price target have analysts set for MOTS?

5 brokerages have issued 12 month price targets for Motus GI's stock. Their forecasts range from $8.00 to $14.50. On average, they expect Motus GI's stock price to reach $10.50 in the next twelve months. This suggests a possible upside of 139.2% from the stock's current price. View Analyst Price Targets for Motus GI.

What is the consensus analysts' recommendation for Motus GI?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motus GI.

Has Motus GI been receiving favorable news coverage?

Headlines about MOTS stock have trended negative on Thursday, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Motus GI earned a news sentiment score of -2.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the immediate future.

Who are some of Motus GI's key competitors?

Who are Motus GI's key executives?

Motus GI's management team includes the folowing people:
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 57)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 48)
  • Mr. Timothy P. Moran, CEO & Director
  • Ms. Hagit Ephrath, VP Health Economics, Regulatory & Clinical Affairs
  • Gil Balog, Gen. Mang. of Israel

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $4.39.

How big of a company is Motus GI?

Motus GI has a market capitalization of $66.06 million and generates $10,000.00 in revenue each year. The company earns $-13,200,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis. Motus GI employs 39 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is http://www.motusgi.com.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 786-459-1831 or via email at [email protected]


MarketBeat Community Rating for Motus GI (NASDAQ MOTS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  93 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel